Neal Hansen is the Managing Director of Hansen Strategy, an independent consulting business focused on advising and facilitating superior decision making in lifecycle management and brand strategy. He has worked with many of the leading pharmaceutical and biotech companies, supporting pipeline, in-line and established brand planning, with a focus on competitive simulations, late stage LCM and emerging markets. Prior to establishing Hansen Strategy, Neal operated as the Global Director of Healthcare Consulting within the Informa Group, leading both Phasic Strategy and Datamonitor Healthcare Consulting. In this role and his previous role as the European Head of Consulting for Wood Mackenzie, he led commercial assessment, scenario planning and war gaming projects for numerous top tier and mid-cap pharmaceutical companies in Europe, the US and Japan.



Earlier in his career, he held various senior roles within Datamonitor including Lead Consultant and Lead Analyst for Strategic and Company Intelligence encompassing Strategic Insight, eHealthInsight and PharmaVitae Company Tracking.



In 2012, Neal co-authored “Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand.” He had previously authored in-depth analyses on strategic issues affecting the pharmaceutical industry, focusing on lifecycle management, pharmaceutical sales force strategies, competitive dynamics in mature and emerging markets and the changing nature of the global generics sector. Neal has chaired and spoken at numerous conferences in the field of lifecycle management and the changing nature of the generics industry and his work has featured in SCRIP Intelligence, The Economist and The Wall Street Journal.



Neal leads the Late Stage Lifecycle Management Training Course for C.E.Lforpharma focusing optimising product strategy at patent expiry and beyond. Neal has also conducted numerous in-house training sessions for Pharmaceutical companies in Lifecycle Management and Competitive Strategy.



Neal holds a PhD in Pharmacology and a MA in Natural Sciences, both from the University of Cambridge.